Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey R Oxnard

Showing results (31-40 of 199) with videos related to

Pageof 20
Sort By:
Academic Medicine : Journal of the Association of American Medical Colleges|August 27, 2009
Integrating research training into residency: tools of human investigationGeoffrey R Oxnard, Tanya Milosh Zinkus, Hasan Bazari, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 3, 2007
Non-small cell lung cancer in octogenarians: treatment practices and preferencesGeoffrey R Oxnard, Panos Fidias, Alona Muzikansky, et al.
The Oncologist|February 13, 2023
BRAF V600E and RNF43 Co-mutations Predict Patient Outcomes With Targeted Therapies in Real-World Cases of Colorectal CancerJulia C F Quintanilha, Ryon P Graf, Geoffrey R Oxnard
Journal of the National Cancer Institute|December 10, 2013
Germline mutations in driver oncogenes and inherited lung cancer risk independent of smoking historyGeoffrey R Oxnard, Kim-Son H Nguyen, Daniel B Costa
Bulletin of the American College of Surgeons|October 13, 2015
Biomarker-driven adjuvant targeted therapy for NSCLC-the ALCHEMIST trialsGeoffrey R Oxnard, Colleen Watt, Dennis Wigle, et al.
The American Journal of Medicine|November 7, 2016
Restoring Balance: Paraneoplastic Cerebellar DegenerationJoshua P Klein, Daniel G Stover, Geoffrey R Oxnard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2011
New strategies in overcoming acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancerGeoffrey R Oxnard, Maria E Arcila, Juliann Chmielecki, et al.
Clinical Lung Cancer|December 4, 2022
Implementation Challenges and Disparities in Molecular Testing for Patients With Stage IV NSCLC: Perspectives from an Urban Safety-Net HospitalLaura Burns, Chinmay Jani, Amr Radwan, et al.
JAMA Oncology|January 1, 2016
Association Between Younger Age and Targetable Genomic Alterations and Prognosis in Non-Small-Cell Lung CancerAdrian G Sacher, Suzanne E Dahlberg, Jennifer Heng, et al.
JAMA Oncology|February 26, 2016
Response Rate as a Regulatory End Point in Single-Arm Studies of Advanced Solid TumorsGeoffrey R Oxnard, Katharine H Wilcox, Mithat Gonen, et al.
Pageof 20

Showing results (31-40 of 199) with videos related to

Sort By:
Pageof 20
Academic Medicine : Journal of the Association of American Medical Colleges|August 27, 2009
Integrating research training into residency: tools of human investigationGeoffrey R Oxnard, Tanya Milosh Zinkus, Hasan Bazari, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 3, 2007
Non-small cell lung cancer in octogenarians: treatment practices and preferencesGeoffrey R Oxnard, Panos Fidias, Alona Muzikansky, et al.
The Oncologist|February 13, 2023
BRAF V600E and RNF43 Co-mutations Predict Patient Outcomes With Targeted Therapies in Real-World Cases of Colorectal CancerJulia C F Quintanilha, Ryon P Graf, Geoffrey R Oxnard
Journal of the National Cancer Institute|December 10, 2013
Germline mutations in driver oncogenes and inherited lung cancer risk independent of smoking historyGeoffrey R Oxnard, Kim-Son H Nguyen, Daniel B Costa
Bulletin of the American College of Surgeons|October 13, 2015
Biomarker-driven adjuvant targeted therapy for NSCLC-the ALCHEMIST trialsGeoffrey R Oxnard, Colleen Watt, Dennis Wigle, et al.
The American Journal of Medicine|November 7, 2016
Restoring Balance: Paraneoplastic Cerebellar DegenerationJoshua P Klein, Daniel G Stover, Geoffrey R Oxnard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2011
New strategies in overcoming acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancerGeoffrey R Oxnard, Maria E Arcila, Juliann Chmielecki, et al.
Clinical Lung Cancer|December 4, 2022
Implementation Challenges and Disparities in Molecular Testing for Patients With Stage IV NSCLC: Perspectives from an Urban Safety-Net HospitalLaura Burns, Chinmay Jani, Amr Radwan, et al.
JAMA Oncology|January 1, 2016
Association Between Younger Age and Targetable Genomic Alterations and Prognosis in Non-Small-Cell Lung CancerAdrian G Sacher, Suzanne E Dahlberg, Jennifer Heng, et al.
JAMA Oncology|February 26, 2016
Response Rate as a Regulatory End Point in Single-Arm Studies of Advanced Solid TumorsGeoffrey R Oxnard, Katharine H Wilcox, Mithat Gonen, et al.
Pageof 20